肝硬变并发自发性细菌性腹膜炎183例临床分析  

Clinical Analysis of 183 Cases Spontaneus Bacterial Peritonitis with Liver Cirrhosis

作　　者：赵红心[1] 张福杰[1] 曹淑芬[1] 

机构地区：[1]北京地坛医院,100011

出　　处：《中西医结合肝病杂志》2000年第4期7-8,共2页Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases

摘　　要：目的:探讨肝硬变并发自发性细菌性腹膜炎(SBP)的诊断、治疗及预防。方法:回顾性分析我院1997年1月～1997年10月183倒临床上诊断为肝硬变并发SBP患者的临床特点、实验室检查及治疗、预后情况。结果:临床上患者均有不同程度的腹痛、腹泻、发热、压痛及反跳痛,腹水细菌培养阳性率8.39%,腹水细胞数符合诊断标准者占60%;治疗上主要选用头孢三代及喹诺酮类,治愈率79.24%。结论:肝硬变并发SBP的诊断不能机械地套用诊断标准.而应综合考虑、全面分析。对严格符合SBP诊断标准的患者,选择头孢三代抗菌素治疗是安全有效的;对疑诊者,可选用喹诺酮类抗菌素,既有很好的治疗作用,又有预防作用。Aim: To explore the diagnosis, therapy and prevention of the SBP with liver cirrhosis. Methods: To analyse retrospectively the clinical features (laboratory tests and treatment of 183 cases SBP with liver cirrhosis. Results: The patients had abdominal pain, diarrhoea, fever, tenderness, rebound tenderness in varying degrees. The positive rate of the bacterial culture in ascites was 8-39%. The consistency of the cell counts in ascites with the diagnosis standards made up 60%. We selected third generation Cephalosporins or Fluoroqindones to treat them. The rate of cure was 79. 24 %. Conclusion: The standard of the diagnosis of SBP should not be applied mechanically, but be analysed all-sided-ly. The ones up to the standard should select third generation Cephalosporins, As for the suspectable patients can select Fluoroqindones to treat or prevent infection.

关 键 词：肝硬变 自发性细菌性腹膜炎 诊断 治疗 

分 类 号：R575.2[医药卫生—消化系统]